NCT04223856 2026-05-29EV-302Astellas Pharma IncPhase 3 Active not recruiting886 enrolled 12 charts 1 FDA
NCT03390504 2026-05-11THORJanssen Research & Development, LLCPhase 3 Active not recruiting629 enrolled 32 charts